Zannes Maria
SEC CIK 1481928 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BIAF | bioAffinity Technologies, Inc. | Pres, CEO, Dir | 280.4K | — | — | 11 | 2022-08-31 | 2025-01-10 |
Most active insiders at BIAF, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
Zannes Maria made no open-market trades at BIAF in the last 12 months.
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-14 | 2025-01-10 | BIAF | bioAffinity Technologies, Inc. | Zannes Maria | Pres, CEO, Dir | A - Grant | $0.00 | +37.0K | 280.4K | +15% | $0 | |
| 2024-07-02 | 2024-07-01 | BIAF | bioAffinity Technologies, Inc. | Zannes Maria | Pres, CEO, Dir | A - Grant | $0.00 | +33.8K | 243.3K | +16% | $0 | |
| 2024-06-14 | 2024-06-12 | BIAF | bioAffinity Technologies, Inc. | Zannes Maria | Pres, CEO, Dir | A - Grant | $0.00 | +8,296 | 209.5K | +4% | $0 | |
| D | 2024-04-24 | 2024-04-08 | BIAF | bioAffinity Technologies, Inc. | Zannes Maria | Pres, CEO | F - Tax | $2.65 | -28.3K | 201.2K | -12% | -$74.9K |
| D | 2024-04-24 | 2024-04-08 | BIAF | bioAffinity Technologies, Inc. | Zannes Maria | Pres, CEO | M - OptEx | $1.16 | +64.8K | 229.5K | +39% | +$75.2K |
| 2024-02-02 | 2024-01-31 | BIAF | bioAffinity Technologies, Inc. | Zannes Maria | Pres, CEO, Dir | A - Grant | $0.00 | +23.9K | 164.7K | +17% | $0 | |
| M | 2024-01-24 | 2023-10-01+ | BIAF | bioAffinity Technologies, Inc. | Zannes Maria | Pres, CEO, Dir | A - Grant | $1.53 | +24.5K | 140.8K | +21% | +$37.5K |
| M | 2023-07-06 | 2023-01-01+ | BIAF | bioAffinity Technologies, Inc. | Zannes Maria | Pres, CEO, Dir | A - Grant | $1.95 | +54.6K | 69.9K | +356% | +$106.3K |
| D | 2022-11-22 | 2022-09-06 | BIAF | bioAffinity Technologies, Inc. | Zannes Maria | Pres, CEO, Dir | C - Cnv Deriv | $4.20 | +23.7K | 43.6K | +119% | +$99.4K |
| D | 2022-11-22 | 2022-11-17 | BIAF | bioAffinity Technologies, Inc. | Zannes Maria | Pres, CEO, Dir | A - Grant | $0.00 | +18.1K | 61.7K | +42% | $0 |
| D | 2022-11-22 | 2022-08-31 | BIAF | bioAffinity Technologies, Inc. | Zannes Maria | Pres, CEO, Dir | P - Purchase | — | +16.3K | 19.9K | +457% | — |
Purchase Sale Sale after option exercise All abbreviations